Development of actionable targets of multi-kinase inhibitors (atomi) screening platform to dissect kinase targets of staurosporines in glioblastoma cells

HIGHLIGHTS

• who: Oxana V. Denisova from the University of Helsinki, Finland have published the paper: Development of actionable targets of multi-kinase inhibitors (AToMI) screening platform to dissect kinase targets of staurosporines in glioblastoma cells, in the Journal: Scientific Reports Scientific Reports

SUMMARY

Bioinformatics analysis MAPK1 PIK3CA ALK PDGFRA EPHB1 NTRK2 TSSK3 HIPK2 TAOK3 IV. Strategy for the characterization of actionable targets of multi‑kinase inhibitors (AToMI). Protein phosphatase 2A (PP2A) inhibition drives resistance to several kinase inhibitors in multiple cancer types, therefore PP2A reactivation could be envisioned as a novel therapeutic opportunity to . . .

 



If you want to have access to all the content you need to log in!

Thanks :)

Username or Email

Password

Remember me

Lost your password?

If you don't have an account, you can create one here.